AIMOVIG vs EDARBYCLOR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. AIMOVIG and EDARBYCLOR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	EDARBYCLOR
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE
Manufacturer	Amgen Inc	Azurity
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	Boxed warning
Half-life	—	about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

aimovig edarbyclor

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

ERENUMAB-AOOE

AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE

Manufacturer

Amgen Inc

Azurity

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Boxed warning

Half-life

—

about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

Frequently asked questions

Which is better-rated, Aimovig or Edarbyclor?

By our independent rating, Aimovig scores higher — 3.6 vs 3.5 out of 5 for Edarbyclor. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aimovig and Edarbyclor?

Aimovig contains Erenumab-Aooe, while Edarbyclor contains Azilsartan Kamedoxomil and Chlorthalidone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.